Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Yuqin Song"'
Publikováno v:
Hematology (Amsterdam, Netherlands). 27(1)
A primary breast lymphomais a rare form of extranodal lymphoma type. We aimed to analyze prognosticriskfactors and explore relapse factors in primary breast diffuse large B cell lymphoma (PB-DLBCL).: From November 2003 to September 2020, sixty-three
Autor:
Chen, Zhang, Lan, Mi, Meng, Wu, Weiping, Liu, Hongmei, Ma, Jianxin, Ren, Linjun, Zhao, Xiaopei, Wang, Yuqin, Song, Jun, Zhu
Publikováno v:
Leukemia & Lymphoma. 63:1152-1159
Angioimmunoblastic T-cell lymphoma (AITL) is a unique sub-type of peripheral T-cell lymphoma (PTCL). We aimed to evaluate treatment programs and prognostic factors of 121 newly diagnosed patients with AITL in China from January 2001 to December 2018.
Publikováno v:
Aging (Albany NY)
Typically, peripheral T-cell lymphoma (PTCLs) prognosis is estimated using overall survival before treatment. However, these estimates cannot show how prognosis evolves with the changing hazard rate over time. Patients (n = 650) with newly diagnosed
Autor:
Weidong Han, Shi Zixiao, Qingzhu Jia, Yajing Zhang, Peter B. Alexander, Pin Wang, Luxiang Xu, Yongsheng Wang, Bo Zhu, Qi-Jing Li, Jia-Nan Cheng, He Feng, Yarong Liu, Qichao Xie, Diyuan Qin, Lina Peng, Zhitao Ying, Jun Zhu, Hongliang Fang, Yuqin Song, Xuejiao Zuo, Jin Tao, Chunyan Hu
Publikováno v:
Theranostics
Rationale: The onset of cytokine release syndrome (CRS) and in vivo persistence of anti-CD19 chimeric antigen receptor T (CAR-T) cells after infusion correlate with clinical responsiveness. However, there are no known baseline biomarkers that can pre
Autor:
Pian Zhang, Dehui Zou, Yuqin Song, Hui Liu, Wenyu Li, Su Yang, Daobin Zhou, Zhitao Ying, Jun Zhu, Jianqiu Wu, Zhao Wang, Haiyan Yang, Mingzhi Zhang, Hongxia Zheng, Ye Guo, Zisong Zhou
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 999-1011 (2021)
Cancer Medicine
Cancer Medicine
Background Despite numerous chimeric antigen receptor T‐cell (CAR‐T) trials conducted in China, no CAR‐T has been registered in the country. Furthermore, China law and regulations restrict the export of patient material for CAR‐T manufacture
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades
Autor:
Jun Zhu, Zhitao Ying, Yuqin Song, Xiaopei Wang, Xin Leng, Lingyan Ping, Xinqiang Ji, Meifeng Tu, Weiping Liu, Chen Zhang, Tingting Du, Yan Xie, Feier Feng, Lijuan Deng, Meng Wu, Ningjing Lin, Yingli Sun, Wen Zheng
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 11, Pp 3765-3774 (2020)
Cancer Medicine, Vol 9, Iss 11, Pp 3765-3774 (2020)
Background The treatment outcomes and prognosis of lymphoma are affected by various factors such as hospital types. This study was to describe the temporal trend in the survival of lymphoma in an academic center in China. Methods A total of 3840 cons
Autor:
Meng Wu, Xiaopei Wang, Ju Zhu, Lijuan Deng, Chen Zhang, Xin Leng, Lingyan Ping, Yan Xie, Wen Zheng, Weiping Liu, Yuqin Song
Publikováno v:
Annals of Hematology. 99:549-555
To evaluate the outcomes of refractory/relapsed cHL patients after high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) in Beijing Cancer hospital and to identify the prognostic risk factors. We retrospectively analyzed 115 r
Autor:
Yaozhong Zhao, Jianda Hu, Jun Luo, Yuqin Song, Liling Zhang, Yan-Yan Liu, Jie Jin, Xinchuan Chen, Jifeng Feng, Jun Zhu, Qingyuan Zhang, Weiwei Wang, Haiwen Huang, Junning Cao, Jianqiu Wu, Chun Xia Chen, Hongwei Xue, T. Lin
Publikováno v:
Clinical Cancer Research. 25:7363-7369
Purpose: For classical Hodgkin lymphoma (cHL), programmed death-l (PD-1) is a well-recognized attractive target. This multicenter, single-arm, phase II study evaluated the efficacy and safety of camrelizumab, a humanized high-affinity IgG4 mAb agains
Autor:
Dehui Zou, Ru Feng, Haiyan Yang, Zhiyue Huang, Jianda Hu, David Simpson, Huilai Zhang, Yongping Song, Daobin Zhou, Sujun Gao, Huafei Lu, Wei Xu, Jianfeng Zhou, Yuqin Song, Keshu Zhou, Jie Jin, Stephen Opat, Tycel Phillips, Jie Ji, Michael Wang, Constantine S. Tam, Fangfang Lv
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Mantle cell lymphoma (MCL) is a mature B-cell neoplasm with a high initial response rate followed almost invariably by relapse. Here we report the pooled data from 2 studies, BGB-3111-AU-003 and BGB-3111-206, to explore the efficacy of zanubrutinib m
Autor:
Lugui Qiu, Huilai Zhang, Zhifeng Li, Zhong Zheng, Kaiyang Ding, Zhi Ming Li, Feili Chen, Ying Xie, Li Wang, Haiyan Yang, Haifeng Yu, Bi-yun Chen, Wenyu Li, Zhijuan Lin, Liyuan Fan, Bing Xu, Manman Deng, Wei-Li Zhao, Lingyan Ping, Yuqin Song, Xiaohua He, Shuhua Yi, Jie Zha, Wei Xu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Clinical features and outcomes of FL patients in Chinese population are limited, thus promoting us to perform this analysis on a large cohort of 1845 patients with FL enrolled from nine medical centers nationwide in China. In this cohort, the median